Risk Minimization Measures

Risk Minimization Measures is a pharmacovigilance strategy comprising intentional interventions or actions designed to prevent or reduce the occurrence or impact of adverse drug reactions through targeted regulatory, educational, or procedural mechanisms.

39

Publications

1.7K

Citations

151

Authors

84

Institutions

Publications per year

2017–2026

13

Authors

151

  1. MS
    Miriam Sturkenboom

    Erasmus MC, Netherlands

    3 publications · 47 citations

    3

    h-index

  2. MY
    Meredith Y. Smith

    Purdue Pharma (United States), United States

    3 publications · 110 citations

    3

    h-index

  3. ÁS
    Álmath Spooner

    European Medicines Agency, Netherlands

    2 publications · 201 citations

    2

    h-index

  4. JR
    June Raine

    Medicines Evaluation Board, Netherlands

    2 publications · 161 citations

    2

    h-index

  5. JH
    Jerry Hanweck

    Morgan Stanley (United States), United States

    2 publications · 37 citations

    2

    h-index

1–5 of 151

Venues

  1. Drug Safety

    5 publications · 263 citations

    5

    h-index

  2. Pharmacoepidemiology and Drug Safety

    4 publications · 116 citations

    4

    h-index

  3. The Journal of Fixed Income

    2 publications · 37 citations

    2

    h-index

  4. The Journal of Finance

    2 publications · 213 citations

    2

    h-index

  5. Toxicology in Vitro

    1 publications · 88 citations

    1

    h-index

1–5